Document Detail


Assessment of lung inflammation with 18F-FDG PET during acute lung injury.
MedLine Citation:
PMID:  20651183     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this review is to describe the current experimental and clinical data regarding the fundamentals and applications of (18)F-FDG PET during acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). CONCLUSION: Lung inflammation is a key feature of ALI. During ALI, FDG PET can be used to monitor lung neutrophils, which are essential cells in the pathophysiologic mechanisms of ALI. Pulmonary FDG kinetics are altered during experimental and human ALI and are associated with regional lung dysfunction, histologic abnormalities, and prognosis. FDG PET may be a valuable noninvasive method for gaining comprehensive understanding of the mechanisms of ALI/ARDS and for evaluating therapeutic interventions.
Authors:
Nicolas de Prost; Mauro R Tucci; Marcos F Vidal Melo
Related Documents :
2989993 - A case of attempted suicide by self-hanging.
12682453 - Epidemiology of acute lung injury.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  195     ISSN:  1546-3141     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-23     Completed Date:  2010-09-24     Revised Date:  2012-04-26    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  292-300     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, 02114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Lung Injury / radionuclide imaging*
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Pneumonia / radionuclide imaging*
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use*
Respiratory Distress Syndrome, Adult / radionuclide imaging*
Grant Support
ID/Acronym/Agency:
HL 5R01HL086827/HL/NHLBI NIH HHS; R01 HL086827-04/HL/NHLBI NIH HHS; R01 HL086827-05/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to kn...
Next Document:  The Challenge of Detector Designs for PET.